BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 7526723)

  • 1. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
    Suster S; Wong TY
    Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin expression in epithelioid vascular neoplasms.
    Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
    Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombomodulin as a marker of vascular and lymphatic tumours.
    Appleton MA; Attanoos RL; Jasani B
    Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma.
    Hagiwara K; Khaskhely NM; Uezato H; Nonaka S
    J Dermatol; 1999 Sep; 26(9):577-86. PubMed ID: 10535252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
    DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
    J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature.
    Burgdorf WH; Mukai K; Rosai J
    Am J Clin Pathol; 1981 Feb; 75(2):167-71. PubMed ID: 6781328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining for CD31 and CD34 in Kaposi sarcoma.
    Russell Jones R; Orchard G; Zelger B; Wilson Jones E
    J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
    Sirgi KE; Wick MR; Swanson PE
    Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.
    Leader M; Collins M; Patel J; Henry K
    Histopathology; 1986 Nov; 10(11):1153-62. PubMed ID: 3100411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.
    Miettinen M; Holthofer H; Lehto VP; Miettinen A; Virtanen I
    Am J Clin Pathol; 1983 Jan; 79(1):32-6. PubMed ID: 6401381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
    Traweek ST; Kandalaft PL; Mehta P; Battifora H
    Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
    Poblet E; Gonzalez-Palacios F; Jimenez FJ
    Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma.
    Sankey EA; More L; Dhillon AP
    J Pathol; 1990 Jul; 161(3):267-71. PubMed ID: 2391587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.
    Chan JK; Frizzera G; Fletcher CD; Rosai J
    Am J Surg Pathol; 1992 Apr; 16(4):335-50. PubMed ID: 1373579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eruptive epithelioid hemangioendothelioma with spindle cells.
    Kanik AB; Hall JD; Bhawan J
    Am J Dermatopathol; 1995 Dec; 17(6):612-7. PubMed ID: 8599479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Eruptive Epithelioid Hemangiomas: A Subset of Cutaneous Cellular Epithelioid Hemangioma With Expression of FOS-B.
    Llamas-Velasco M; Kempf W; Cota C; Fernández-Figueras MT; Lee J; Ferrara G; Sander C; Shapiro PE; Requena L; Kutzner H
    Am J Surg Pathol; 2019 Jan; 43(1):26-34. PubMed ID: 29266025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.
    Anthony PP; Ramani P
    J Clin Pathol; 1991 Jan; 44(1):29-32. PubMed ID: 1705261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.